QIAGEN N.V. (QGEN) stock
QGENNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$46.55+0.42 (+0.91%)
Close on Oct 19, 2026Market cap –P/E 24.0Yield 0.54%
Qiagen free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2025 it was $453.28M, down 10.5% from the year before. Over ten years it grew 7.5% a year on average. The highest annual figure on record is $586.04M in fiscal 2022.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $453.28M | -10.5% |
| FY2024 | Dec 31, 2024 | $506.38M | +63.5% |
| FY2023 | Dec 31, 2023 | $309.75M | -47.1% |
| FY2022 | Dec 31, 2022 | $586.04M | +30.5% |
| FY2021 | Dec 31, 2021 | $449.10M | +38.2% |
| FY2020 | Dec 31, 2020 | $325.02M | +52.7% |
| FY2019 | Dec 31, 2019 | $212.89M | -14.7% |
| FY2018 | Dec 31, 2018 | $249.72M | +27.0% |
| FY2017 | Dec 31, 2017 | $196.70M | -26.3% |
| FY2016 | Dec 31, 2016 | $267.07M | +21.5% |
| FY2015 | Dec 31, 2015 | $219.72M | +9.1% |
| FY2014 | Dec 31, 2014 | $201.37M | +15.4% |
| FY2013 | Dec 31, 2013 | $174.49M | +22.1% |
| FY2012 | Dec 31, 2012 | $142.88M | -9.6% |
| FY2011 | Dec 31, 2011 | $157.97M | -7.7% |
| FY2010 | Dec 31, 2010 | $171.09M | +3.8% |
| FY2009 | Dec 31, 2009 | $164.82M | +23.4% |
| FY2008 | Dec 31, 2008 | $133.55M | – |
See a number that looks wrong?